Endo Lidoderm Shingles Pain Patch Launch Awaits Manufacturing Scale-Up
Executive Summary
Launch of Endo Pharmaceuticals' Lidoderm patch for post-herpetic neuralgia pain is pending completion of manufacturing scale-up for commercial distribution.
You may also be interested in...
Neurontin Pain Claim Follows Cmte. Preference For Individual Etiologies
Pfizer's Neurontin postherpetic neuralgia indication closely follows a recent advisory committee recommendation that indications for individual etiologies of neuropathic pain would be preferable to a broad claim
Neurontin Pain Claim Follows Cmte. Preference For Individual Etiologies
Pfizer's Neurontin postherpetic neuralgia indication closely follows a recent advisory committee recommendation that indications for individual etiologies of neuropathic pain would be preferable to a broad claim
Algos MorphiDex Has Dec. 31, 2001 Deadline For FDA Approval In Endo Deal
Algos has an upcoming Dec. 13 meeting with FDA regarding the future of its cancer pain treatment MorphiDex that could influence the value of the company's proposed merger with Endo Pharmaceuticals.